A device for easing migraine pain, renovated veterans housing in Florida and an 100-year-old former Rosie the Riveter, Irene ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Despite mixed results from its experimental schizophrenia treatment last month, MapLight Therapeutics is going all-in on the asset—at the expense of its preclinical programs. In its second-quarter ...

Centanafadine belongs to a new class of ADHD medicines. It’s the first to affect three brain chemicals: noradrenaline (known ...

A new pancreatic cancer drug nearly doubled survival in a major trial, giving patients and doctors new hope against a deadly disease.

In this video, we explore two intriguing locations: an abandoned ghost town linked to a serial killer and a decaying mansion featuring a car graveyard that once belonged to a famous artist. The ...

Share on Pinterest The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a ...

Businesses in the health and wellness industry are getting a boost, thanks to off-label usage and doctor’s orders.

TONMYA® net sales totaled approximately $11 million, an increase of 197% quarter-over-quarter Commercial and government payer coverage for ...

Adolescents and young adults with chronic migraines saw significant reductions in daily headaches and in headache disability scores after treatments of onabotulinumtoxin A, according to data published ...

The FDA approved the first drug to treat a root cause of narcolepsy, which could help other sleep conditions as well.

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the ...